CTS: Sequential Erlotinib Therapy Influences Progression-Free Survival in NSCLC

Published on Wednesday 19 November 2008 - 12:29

Summary :
CHICAGO (MedPage Today) -- Progression-free survival among non-small-cell lung cancer patients improved if they were treated with erlotinib (Tarceva) in a sequential treatment strategy as opposed...
Read more

Information source

MedPageToday.com - Latest medical news and health news plus CME for physicians and healthcare professionals

http://www.medpagetoday.com/

Website description
Medpage Today is a CE and CME accredited medical news service, which provides daily coverage of developments that impact clinical practice, and offers free continuing medical education courses and...

Articles published on this website : 2 / 7 days - 50 / 30 days

Breast Cancer Metastasis Gene Identified Silencing of a Single Gene May Trigger Lung Body Weight Makes No Difference in Ovarian Cancer Nutritional Supplements Again Fail to Cut Risk of SABCS: Breast Cancer Fear Common Among Adolescent Girls

Other articles published on other websites on the same day

Purdue Mann Institute Reveals First Round Of Biomed Tech-Commercialization Awards http://www.biotechtransferweek.com/ University of Kansas Research Arm Sues US Government Over Cancer Drug Inventorship http://www.biotechtransferweek.com/ Dancing for a cause - a cure for breast cancer http://www.gulfbreezenews.com/ Randy Credico: American Injustice -- Anthony Williams and New York's Drug Laws http://www.huffingtonpost.com/ BOOK REVIEW: Cancer Supportive Care: Advances in Therapeutic Strategies http://content.nejm.org/ Teens overlooked in clinical trials http://www.fiercebiotech.com/ Quintuple Bottom Breaks http://www.istockanalyst.com/ Robotic Surgery Allows Cancer Patients To Have Kids http://www.wdsu.com/ Lilly Offers Free Health Guide, Available throughout State http://www.hispanicbusiness.com/ European patent office restores breast cancer gene patent http://news.sawf.org/